Email this article Pharmacopoeial Quality Requirements for Compounded Pharmaceuticals: Present and Future
- Authors: Shishova L.I.1, Sakanyan E.I.1, Shemeryankina T.B.1, Gubareva O.N.1
-
Affiliations:
- Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- Issue: Vol 51, No 8 (2017)
- Pages: 731-734
- Section: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/244778
- DOI: https://doi.org/10.1007/s11094-017-1683-3
- ID: 244778
Cite item
Open Access
Access granted
Subscription Access
Abstract
Issues related to regulation of the quality of compounded medicinal preparations by the State Pharmacopoeia of the Russian Federation are considered. Topical questions of the development and implementation of both general clauses and particular monographs related to compounded pharmaceuticals in national pharmacopoeial science and practice are discussed.
About the authors
L. I. Shishova
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051
E. I. Sakanyan
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051
T. B. Shemeryankina
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051
O. N. Gubareva
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Russian Federation, 8/2 Petrovskii Blvd., Moscow, 127051
